Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Income Statement
Earnings Waterfall
Biohaven Pharmaceutical Holding Company Ltd
Revenue
|
0
USD
|
Operating Expenses
|
-436.1m
USD
|
Operating Income
|
-436.1m
USD
|
Other Expenses
|
27.9m
USD
|
Net Income
|
-408.2m
USD
|
Income Statement
Biohaven Pharmaceutical Holding Company Ltd
Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|
Revenue | ||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||
Operating Expenses |
(568)
|
(556)
|
(453)
|
(496)
|
(436)
|
|
Selling, General & Administrative |
(131)
|
(126)
|
(120)
|
(120)
|
(63)
|
|
Research & Development |
(437)
|
(430)
|
(333)
|
(376)
|
(373)
|
|
Operating Income |
(568)
N/A
|
(556)
+2%
|
(453)
+19%
|
(496)
-9%
|
(436)
+12%
|
|
Pre-Tax Income | ||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(2)
|
6
|
12
|
17
|
27
|
|
Pre-Tax Income |
(570)
N/A
|
(550)
+4%
|
(441)
+20%
|
(479)
-9%
|
(410)
+14%
|
|
Net Income | ||||||
Tax Provision |
(0)
|
6
|
10
|
14
|
1
|
|
Income from Continuing Operations |
(570)
|
(544)
|
(431)
|
(465)
|
(408)
|
|
Net Income (Common) |
(570)
N/A
|
(544)
+5%
|
(431)
+21%
|
(465)
-8%
|
(408)
+12%
|
|
EPS (Diluted) |
-8.36
N/A
|
-7.97
+5%
|
-6.31
+21%
|
-6.8
-8%
|
-5.73
+16%
|